NASDAQ:BMRN
$90.74
(
0.699%
)
Friday, 24th Mar 2023
BioMarin Pharmaceutical Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $87.34 | $105.69 | Friday, 24th Mar 2023 BMRN stock ended at $90.74. This is 0.699% more than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 2.04% from a day low at $89.34 to a day high of $91.16. |
| 90 days | $87.34 | $117.77 | |
| 52 weeks | $70.73 | $117.77 |
Historical BioMarin Pharmaceutical Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2021-08-20 | $74.86 | $75.54 | $74.65 | $75.14 | 1 238 735 |
| 2021-08-19 | $75.51 | $76.74 | $74.68 | $74.77 | 1 155 865 |
| 2021-08-18 | $76.58 | $76.67 | $75.34 | $75.54 | 726 320 |
| 2021-08-17 | $74.79 | $76.53 | $74.60 | $76.36 | 911 188 |
| 2021-08-16 | $74.73 | $75.42 | $73.95 | $75.10 | 835 952 |
| 2021-08-13 | $75.71 | $76.23 | $74.95 | $75.03 | 925 981 |
| 2021-08-12 | $75.75 | $76.00 | $74.86 | $75.39 | 718 361 |
| 2021-08-11 | $77.00 | $77.49 | $75.50 | $75.72 | 1 059 859 |
| 2021-08-10 | $77.54 | $77.75 | $76.48 | $76.89 | 790 437 |
| 2021-08-09 | $78.45 | $78.55 | $77.22 | $77.50 | 1 051 281 |
| 2021-08-06 | $78.17 | $78.73 | $76.91 | $78.13 | 1 068 199 |
| 2021-08-05 | $76.51 | $77.93 | $76.21 | $77.93 | 1 145 341 |
| 2021-08-04 | $77.17 | $77.88 | $76.01 | $76.44 | 897 208 |
| 2021-08-03 | $77.63 | $77.75 | $76.41 | $77.65 | 785 710 |
| 2021-08-02 | $76.69 | $77.74 | $76.50 | $77.41 | 981 776 |
| 2021-07-30 | $78.60 | $78.80 | $76.62 | $76.73 | 908 977 |
| 2021-07-29 | $78.75 | $81.56 | $78.36 | $78.51 | 1 136 046 |
| 2021-07-28 | $78.27 | $79.34 | $78.18 | $78.73 | 663 264 |
| 2021-07-27 | $77.55 | $78.50 | $76.50 | $78.33 | 926 758 |
| 2021-07-26 | $76.91 | $77.97 | $76.61 | $77.35 | 994 489 |
| 2021-07-23 | $78.88 | $78.88 | $76.42 | $77.04 | 1 455 198 |
| 2021-07-22 | $79.39 | $79.77 | $78.42 | $78.46 | 597 969 |
| 2021-07-21 | $79.48 | $80.01 | $78.44 | $79.65 | 678 389 |
| 2021-07-20 | $79.25 | $80.17 | $78.95 | $79.50 | 1 168 786 |
| 2021-07-19 | $77.39 | $79.24 | $77.35 | $78.77 | 1 045 997 |
| 2021-07-16 | $79.95 | $80.06 | $78.45 | $78.84 | 851 637 |
| 2021-07-15 | $79.39 | $79.99 | $78.29 | $79.57 | 1 381 176 |
| 2021-07-14 | $81.66 | $81.78 | $79.58 | $79.68 | 942 515 |
| 2021-07-13 | $81.99 | $82.39 | $81.22 | $81.50 | 495 206 |
| 2021-07-12 | $83.84 | $83.84 | $81.81 | $82.33 | 611 835 |
| 2021-07-09 | $83.13 | $83.72 | $82.79 | $83.62 | 604 678 |
| 2021-07-08 | $82.26 | $83.58 | $81.50 | $82.95 | 1 014 679 |
| 2021-07-07 | $84.75 | $84.80 | $82.88 | $83.04 | 1 167 706 |
| 2021-07-06 | $85.35 | $85.35 | $84.00 | $84.57 | 823 441 |
| 2021-07-02 | $84.23 | $85.74 | $83.46 | $85.47 | 946 784 |
| 2021-07-01 | $83.26 | $83.95 | $82.97 | $83.91 | 827 224 |
| 2021-06-30 | $83.42 | $83.82 | $82.75 | $83.44 | 769 485 |
| 2021-06-29 | $84.23 | $85.20 | $82.96 | $83.46 | 606 263 |
| 2021-06-28 | $85.79 | $86.33 | $83.87 | $84.43 | 519 316 |
| 2021-06-25 | $84.33 | $85.50 | $83.20 | $84.79 | 3 891 045 |
| 2021-06-24 | $83.23 | $84.17 | $82.91 | $83.78 | 1 081 544 |
| 2021-06-23 | $80.79 | $82.87 | $80.79 | $82.58 | 1 252 233 |
| 2021-06-22 | $80.92 | $81.53 | $80.14 | $81.14 | 1 197 969 |
| 2021-06-21 | $82.06 | $82.60 | $80.43 | $80.76 | 1 092 492 |
| 2021-06-18 | $82.54 | $82.90 | $81.52 | $81.90 | 1 339 902 |
| 2021-06-17 | $82.54 | $83.76 | $82.04 | $82.98 | 820 917 |
| 2021-06-16 | $82.13 | $82.68 | $81.35 | $82.48 | 1 028 627 |
| 2021-06-15 | $82.40 | $82.76 | $81.19 | $81.96 | 549 905 |
| 2021-06-14 | $82.49 | $83.45 | $82.17 | $82.48 | 632 335 |
| 2021-06-11 | $83.55 | $83.85 | $81.75 | $82.07 | 743 066 |
About BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
